Dr. Ravi Sarode MD

Co-Editor-in-Chief, "Transfusion and Apheresis Science” Journal, John H. Childers, MD, Professorship in Pathology, Professor (Tenure) of Pathology and Internal Medicine (Hematology/Oncology), Chief of Pathology and Medical Director, UTSW Clinical Laborato, UT Southwestern Medical Center, Department of Pathology, Division of Transfusion Medicine and Hemostasis

Dr. Ravi Sarode is a Tenured Professor of Pathology and Internal Medicine (Hematology/Oncology), the Chief of Pathology, and the Medical Director of Clinical Laboratory Services at the University of Texas Southwestern Medical Center in Dallas. He is also the Medical Director of the Division of Transfusion Medicine and Hemostasis. He holds the John H. Childers, MD, Professorship in Pathology. Dr. Sarode has been actively involved in clinical research (Thrombotic Thrombocytopenic Purpura, Heparin Induced Thrombocytopenia, Therapeutic Apheresis in general and, red cell exchange in sickle cell anemia in particular, antiphospholipid antibody syndrome, platelet function disorders, reducing the misuse of blood products in clinical practice, Prothrombin Complex Concentrates, direct oral anticoagulants and, recently on rebalanced hemostasis of cirrhosis and restrictive transfusions). He has participated in 13 clinical trials, participated as a coordinating investigator for two completed international trials for Kcentra and leading another international clinical trial comparing Kcentra with Octaplex for VKA reversal for urgent surgery. He has published more than 170 articles and written 17 book chapters. He is a Co-Editor-in-Chief of “Transfusion and Apheresis Science”. He is the past president of the American Society for Apheresis (ASFA), and recipient of ASFA Presidential Award, Outstanding Physician Award at University Hospitals of Cleveland and the Vernie A. Stembridge Resident Teaching Award. He was honored as the “Choosing Wisely Champion” for his work on reducing unnecessary thrombophilia testing at annual American Society of Hematology meeting in San Diego 2016. He was invited to participate in writing guidelines by American Heart Association (2016-17) and Society for Interventional Radiology (2017-18) involving hemostasis and transfusions. He is a board member for “Foundation for Women and Girls with Bleeding Disorders” and co-chairs Hematology “Fellow’s work shop” at HTRS. His passion is to educate clinicians on appropriate use of blood components and laboratory testing to avoid harm to the patients, use limited resources judiciously and reduce healthcare cost.


This speaker has made no appearances.